DekaBank Deutsche Girozentrale - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$7,000
-96.4%
80,500
-18.7%
0.00%
-100.0%
Q3 2018$192,000
+13.6%
99,0000.0%0.00%0.0%
Q2 2018$169,000
-3.4%
99,0000.0%0.00%0.0%
Q1 2018$175,000
-42.1%
99,000
-2.0%
0.00%
-50.0%
Q4 2017$302,0000.0%101,0000.0%0.00%0.0%
Q3 2017$302,000
-31.4%
101,0000.0%0.00%
-33.3%
Q2 2017$440,000
-6.6%
101,0000.0%0.00%
-25.0%
Q1 2017$471,000
-27.3%
101,000
-7.8%
0.00%
-42.9%
Q4 2016$648,000
+20.9%
109,500
+8.4%
0.01%
+16.7%
Q3 2016$536,000
+41.8%
101,0000.0%0.01%
+50.0%
Q2 2016$378,000
+118.5%
101,000
+59.1%
0.00%
+100.0%
Q1 2016$173,000
-46.6%
63,500
+11.4%
0.00%
-50.0%
Q4 2015$324,000
+8.4%
57,000
+0.9%
0.00%0.0%
Q3 2015$299,000
-23.1%
56,500
+20.2%
0.00%
-20.0%
Q2 2015$389,000
+85.2%
47,000
+3.3%
0.01%
+66.7%
Q1 2015$210,000
+32.9%
45,500
-10.8%
0.00%
+50.0%
Q4 2014$158,000
+2.6%
51,000
-8.1%
0.00%0.0%
Q3 2014$154,000
-29.4%
55,500
+3.7%
0.00%
-33.3%
Q2 2014$218,000
-25.3%
53,500
-2.7%
0.00%
-40.0%
Q1 2014$292,000
+0.7%
55,000
+6.8%
0.01%0.0%
Q4 2013$290,000
+25.5%
51,500
+2.0%
0.01%
+25.0%
Q3 2013$231,00050,5000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,200,000$6,072,0002.38%
GREAT POINT PARTNERS LLC 2,175,000$6,003,0002.15%
Belmont Global Advisors, Inc. 400,000$1,104,0001.12%
Trellus Management Company, LLC 162,900$450,0000.78%
PURA VIDA INVESTMENTS, LLC 572,800$1,581,0000.72%
DAFNA Capital Management LLC 294,563$813,0000.70%
Twin Securities, Inc. 1,687,115$4,656,0000.58%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 1,000,000$2,760,0000.33%
WALL STREET ASSOCIATES 269,300$743,0000.31%
Paulson & Co. 11,090,000$30,608,0000.23%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders